Use of Erythropoietin in Ophthalmology: a Review
Overview
Affiliations
Erythropoietin (EPO) is a glycoprotein hormone that regulates hematopoiesis in the human body. The presence of EPO and its receptors in different tissues indicates that this hormone has extramedullary effects in other tissues, including the eye. We focus on the biological roles of this hormone in the development and normal physiologic functions of the eye. Furthermore, we explore the role of EPO in the management of different ocular diseases - including diabetic retinopathy, retinopathy of prematurity, inherited retinal degeneration, branch and central retinal vein occlusion, retinal detachment, traumatic optic neuropathy, optic neuritis, methanol optic neuropathy, nonarteritic anterior ischemic optic neuropathy, glaucoma, and scleral necrosis.
Therapeutic role of erythropoietin in methanol induced optic neuropathy: a systematic review.
Feizi N, Mohamadzadeh-Nabiei M, Vahedi H, Farabi Maleki S, Jafarizadeh A Daru. 2024; 33(1):2.
PMID: 39613913 PMC: 11607285. DOI: 10.1007/s40199-024-00551-w.
Titz B, Siebourg-Polster J, Bartolo F, Lavergne V, Jiang Z, Gayan J Transl Vis Sci Technol. 2024; 13(6):17.
PMID: 38913008 PMC: 11205237. DOI: 10.1167/tvst.13.6.17.
Risk of Induction of Corneal Neovascularization with Topical Erythropoietin: An Animal Safety Study.
Feizi S, Kanavi M, Abolhosseini M, Moshtaghion S, Esfandiari H J Ophthalmic Vis Res. 2024; 18(3):252-259.
PMID: 38737499 PMC: 11082528. DOI: 10.18502/jovr.v18i3.13772.
Mai K, Su R, Basalely A, Castellanos L, Singer P, Pomeranz H Pediatr Nephrol. 2024; 39(6):1771-1774.
PMID: 38197957 DOI: 10.1007/s00467-023-06252-x.
Erythropoiesis-Stimulating Agents and the Risk of Vision-Threatening Diabetic Retinopathy.
Tsui J, Willett K, Cohen J, Yu Y, VanderBeek B Ophthalmic Epidemiol. 2023; 31(3):249-257.
PMID: 37427852 PMC: 10776797. DOI: 10.1080/09286586.2023.2235001.